Serum hepcidin and iron absorption in paediatric inflammatory bowel disease

Journal of Crohn's and Colitis

Volumn 10, Issue 5, 2016, Pages 566-574

  Martinelli, Massimo ^a   Strisciuglio, Caterina ^b   Alessandrella, Annalisa ^a   Rossi, Francesca ^b   Auricchio, Renata ^a   Campostrini, Natascia ^c   Girelli, Domenico ^c   Nobili, Bruno ^b   Staiano, Annamaria ^a   Perrotta, Silverio ^b   Miele, Erasmo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

Hepcidin; IBD; Iron absorption

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CALGRANULIN; FERRITIN; HEMOGLOBIN; HEPCIDIN; IMMUNOSUPPRESSIVE AGENT; IRON; MESALAZINE; METHOTREXATE; STEROID; TRANSFERRIN RECEPTOR; BIOLOGICAL MARKER; HEPCIDIN 25, HUMAN;

ADOLESCENT; ADULT; ARTICLE; BLOOD CELL COUNT; CELIAC DISEASE; CHILD; CONTROLLED STUDY; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; CROSS-SECTIONAL STUDY; DIGESTIVE SYSTEM DISEASE ASSESSMENT; DISEASE ACTIVITY; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; ERYTHROPOIESIS; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; INFLAMMATORY BOWEL DISEASE; IRON ABSORPTION; MAJOR CLINICAL STUDY; MALE; PAEDIATRIC ULCERATIVE COLITIS ACTIVITY INDEX; PANCOLITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ULCERATIVE COLITIS; ANEMIA, IRON-DEFICIENCY; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; COMPLICATION; PRESCHOOL CHILD; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL;

ADOLESCENT; ANEMIA, IRON-DEFICIENCY; BIOMARKERS; CASE-CONTROL STUDIES; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FERRITINS; HEPCIDINS; HUMANS; IRON; LOGISTIC MODELS; MALE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84982196277     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1093/ecco-jcc/jjv242     Document Type: Article

References (36)

1. Gasche C, Lomer MCE, Cavill I, Weiss G. Iron, anemia, and inflammatory bowel diseases. Gut 2004;53:1190-7.
2. Wells CW, Lewis S, Barton JR, Corbett S. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis 2006;12:123-30.
3. Goodhand JR, Kamperidis N, Rao A, et al. Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease. Inflamm Bowel Dis 2012;18:513-9.
4. Oustamanolakis P, Koutroubakis IE, Kouroumalis EA. Diagnosing anemia in inflammatory bowel disease: beyond the established markers. J Crohns Colitis 2011;5:381-91.
5. Zhu A, Kaneshiro M, Kaunitz JD. Evaluation and treatment of iron deficiency anemia: a gastroenterological perspective. Dig Dis Sci 2010;55:548-59.
6. Weiss G, Gasche C. Pathogenesis and treatment of anemia in inflammatory bowel disease. Haematologica 2010;95:175-8.
7. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001;276:7806-10.
8. Ganz T. Hepcidin. a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003;102:783-8.
9. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004;113:1271-6.
10. Lee P, Peng H, Gelbart T, Wang L, Beutler E. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci U S A 2005;102:1906-10.
11. Semrin G, Fishman DS, Bousvaros A, et al. Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation. Inflamm Bowel Dis 2006;12:1101-6.
12. Oustamanolakis P, Koutroubakis IE, Messaritakis I, Malliaraki N, Sfiridaki A, Kouroumalis EA. Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease. Eur J Gastroenterol Hepatol 2011;23:262-8.
13. Arnold J, Sangwaiya A, Bhatkal B, Geoghegan F, Busbridge M. Hepcidin and inflammatory bowel disease: dual role in host defence and iron homoeostasis. Eur J Gastroenterol Hepatol 2009;21:425-9.
14. Kaya Z, Yildiz E, Gursel T, et al. Serum prohepcidin levels in children with solid tumors, inflammatory bowel disease and iron deficiency anemia. J Trop Pediatr 2011;57:120-5.
15. Nagy J, Lakner L, Poór VS, et al. Serum prohepcidin levels in chronic inflammatory bowel diseases. J Crohns Colitis 2010;4:649-53.
16. IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis the Porto criteria. J Pediatr Gastroenterol Nutr 2005;41:1-7.
17. Bergamaschi G, Di Sabatino A, Albertini R, et al. Serum hepcidin in inflammatory bowel diseases: biological and clinical significance. Inflamm Bowel Dis 2013;19:2166-72.
18. Campostrini N, Castagna A, Zaninotto F, et al. Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDITOF MS. J Biomed Biotechnol 2010;2010:329646.
19. Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011;17:1314-21.
20. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991;12:439-47.
21. Turner D, Otley AR, Mack D, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology 2007;133:423-32.
22. WHO, UNICEF, UNU. Iron Deficiency Anemia: Assessment, Prevention and Control. Report of a joint WHO/UNICEF/UNU consultation. Geneva: World Health Organization, 1998.
23. Dignass AU, Gasche C, Bettenworth D, et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis 2015;9:211-22.
24. De Vizia B, Poggi V, Conenna R, Fiorillo A, Scippa L. Iron absorption and iron deficiency in infants and children with gastrointestinal diseases. J Pediatr Gastroenterol Nutr 1992;14:21-6.
25. Ott C, Liebold A, Takses A, Strauch UG, Obermeier F. High prevalence but insufficient treatment of iron-deficiency anemia in patients with inflammatory bowel disease: results of a population-based cohort. Gastroenterol Res Pract 2012;2012:595970.
26. Lugg S, Beal F, Nightingale P, Bhala N, Iqbal T. Iron treatment and inflammatory bowel disease: What happens in real practice? J Crohn's Colitis 2014;8:876-80.
27. Lee TW, Kolber MR, Fedorak RN, van Zanten SV. Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis. J Crohns Colitis 2012;6:267-75.
28. De Silva AD, Tsironi E, Feakins RM, Rampton DS. Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial. Aliment Pharmacol Ther 2005;22:1097-105.
29. Seril DN, Liao J, West AB, Yang GY. High-iron diet: foe or feat in ulcerative colitis and ulcerative colitis-associated carcinogenesis. J Clin Gastroenterol 2006;40:391-7.
30. Oldenburg B, Berge Henegouwen GP, Rennick D, Van Asbeck BS, Konigsberger JC. Iron supplementation affects the production of pro-inflammatory cytokines in IL-10 deficient mice. Eur J Clin Invest 2000;30:505-10.
31. Zimmermann MB, Chassard C, Rohner F, et al. The effects of iron fortification on the gut microbiota in African children: a randomized controlled trial in Cote d'Ivoire. Am J Clin Nutr 2010;92:1406-15.
32. Oustamanolakis P, Koutroubakis IE. Soluble transferrin receptor-ferritin index is the most efficient marker for the diagnosis of iron deficiency anemia in patients with IBD. Inflamm Bowel Dis 2011;17:E158-9.
33. Wang L, Trebicka E, Fu Y, et al. The bone morphogenetic protein-hepcidin axis as a therapeutic target in inflammatory bowel disease. Inflamm Bowel Dis 2012;18:112-9.
34. Mecklenburg I, Reznik D, Fasler-Kan E, Drewe J, Beglinger C, Hruz P. On behalf of the Swiss IBD Cohort Study Group. Serum hepcidin concentrations correlate with ferritin in patients with inflammatory bowel disease. J Crohns Colitis 2014;8:1392-7.
35. Young MF, Glahn RP, Ariza-Nieto M, et al. Serum hepcidin is significantly associated with iron absorption from food and supplemental sources in healthy young women. Am J Clin Nutr 2009;89:533-8.
36. Roe MA, Collings R, Dainty JR, Swinkels DW, Fairweather-Tait SJ. Plasma hepcidin concentrations significantly predict interindividual variation in iron absorption in healthy men. Am J Clin Nutr 2009;89:1088-91.